1. Home
  2. XTNT vs MCHX Comparison

XTNT vs MCHX Comparison

Compare XTNT & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.60

Market Cap

88.7M

Sector

Health Care

ML Signal

HOLD

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.42

Market Cap

61.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XTNT
MCHX
Founded
N/A
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
88.7M
61.5M
IPO Year
2009
2003

Fundamental Metrics

Financial Performance
Metric
XTNT
MCHX
Price
$0.60
$1.42
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
90.8K
9.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
52.17
EPS
0.03
N/A
Revenue
$53,337,000.00
$90,291,000.00
Revenue This Year
$15.08
N/A
Revenue Next Year
N/A
$6.70
P/E Ratio
$20.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.26
52 Week High
$0.95
$2.30

Technical Indicators

Market Signals
Indicator
XTNT
MCHX
Relative Strength Index (RSI) 47.99 54.56
Support Level $0.55 $1.35
Resistance Level $0.68 $1.76
Average True Range (ATR) 0.05 0.05
MACD 0.00 0.01
Stochastic Oscillator 33.94 93.75

Price Performance

Historical Comparison
XTNT
MCHX

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: